Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Rare case of simultaneous manifestation of pigmented paravenous retinochoroidal atrophy and retinitis pigmentosa in contralateral eye.

Mehrotra N, Khandelwal J, Nagpal M.

Indian J Ophthalmol. 2019 Nov;67(11):1875-1876. doi: 10.4103/ijo.IJO_372_19. No abstract available.

2.

Illness Perceptions of African-Americans with Chronic Kidney Disease.

Calvin DJ, Grumbach G, Dancy B, Tahsin B, Fogelfeld L, Mehrotra R, Mehrotra N.

J Natl Black Nurses Assoc. 2019 Jul;30(1):21-28.

PMID:
31465681
3.

PREOPERATIVE AND POSTOPERATIVE MACULAR SENSITIVITY ASSESSMENT USING MICROPERIMETRY IN EYES UNDERGOING SILICONE OIL REMOVAL.

Nagpal M, Khandelwal J, Eltayib A, Mehrotra N, Juneja R.

Retina. 2019 Aug 9. doi: 10.1097/IAE.0000000000002629. [Epub ahead of print]

PMID:
31404034
4.

Periodontitis.

Mehrotra N, Singh S.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 May 5.

5.

Correlation of "Panoramic" Optical Coherence Tomography Angiography With Indocyanine Green Angiography Characteristics of Serpiginous-Like Choroiditis.

Nagpal M, Mehrotra N, Juneja R, Vishnoi A, Jain A.

Ophthalmic Surg Lasers Imaging Retina. 2018 Nov 1;49(11):859-869. doi: 10.3928/23258160-20181101-07.

PMID:
30457645
6.

Panoramic optical coherence tomography angiography features in acute zonal occult outer retinopathy.

Mehrotra N, Nagpal M, Khandelwal J, Juneja R.

Indian J Ophthalmol. 2018 Dec;66(12):1856-1858. doi: 10.4103/ijo.IJO_826_18. No abstract available.

7.

Correlation of optical coherence tomography angiography and microperimetry (MP3) features in wet age-related macular degeneration.

Nagpal M, Khandelwal J, Juneja R, Mehrotra N.

Indian J Ophthalmol. 2018 Dec;66(12):1790-1795. doi: 10.4103/ijo.IJO_866_18.

8.

PDUFA VI: It Is Time to Unleash the Full Potential of Model-Informed Drug Development.

Jain L, Mehrotra N, Wenning L, Sinha V.

CPT Pharmacometrics Syst Pharmacol. 2019 Jan;8(1):5-8. doi: 10.1002/psp4.12365. Epub 2018 Nov 29. No abstract available.

9.

Comment on: Sandwich technique using a combination of perfluoropropane and silicone oil for inferior retinal detachment.

Mehrotra N.

Indian J Ophthalmol. 2018 Nov;66(11):1657. doi: 10.4103/ijo.IJO_1356_18. No abstract available.

10.

Use of a Systems Pharmacology Model Based Approach Toward Dose Optimization of Parathyroid Hormone Therapy in Hypoparathyroidism.

Khurana M, Zadezensky I, Lowy N, Roman D, Guettier JM, Li L, Florian J, Sahajwalla CG, Sinha V, Mehrotra N.

Clin Pharmacol Ther. 2019 Mar;105(3):710-718. doi: 10.1002/cpt.1200. Epub 2018 Oct 22.

PMID:
30350311
11.

Dexamethasone implant (0.7 mg) in Indian patients with macular edema: Real-life scenario.

Nagpal M, Mehrotra N, Juneja R, Jain H.

Taiwan J Ophthalmol. 2018 Jul-Sep;8(3):141-148. doi: 10.4103/tjo.tjo_62_17.

12.

Chandelier-assisted retroillumination for phacoemulsification in phacovitrectomy.

Nagpal MP, Mahuvakar SA, Chaudhary PP, Mehrotra NS, Jain AK.

Indian J Ophthalmol. 2018 Aug;66(8):1094-1097. doi: 10.4103/ijo.IJO_85_18.

13.

Isolated Langerhans Cell Histiocytosis of Orbit: A Case Report and Review of the Literature.

Naik M, Mehta A, Mehrotra N, Solanki A.

Case Rep Ophthalmol Med. 2018 Apr 4;2018:1529281. doi: 10.1155/2018/1529281. eCollection 2018.

14.

Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer.

Hiraki M, Maeda T, Mehrotra N, Jin C, Alam M, Bouillez A, Hata T, Tagde A, Keating A, Kharbanda S, Singh H, Kufe D.

Signal Transduct Target Ther. 2018 May 12;3:13. doi: 10.1038/s41392-018-0013-x. eCollection 2018.

15.

Disseminated cryptococcosis in HIV negative patient.

Hassoun A, Mehrotra N.

BMJ Case Rep. 2018 May 12;2018. pii: bcr-2017-223500. doi: 10.1136/bcr-2017-223500.

PMID:
29754135
16.

Quantitative Understanding of QTc Prolongation and Gender as Risk Factors for Torsade de Pointes.

Johannesen L, Garnett C, Luo M, Targum S, Sørensen JS, Mehrotra N.

Clin Pharmacol Ther. 2018 Feb;103(2):304-309. doi: 10.1002/cpt.783. Epub 2017 Dec 8.

PMID:
29219167
17.

Comparison of clinical outcome between 23-G and 25-G vitrectomy in diabetic patients.

Taleb EA, Nagpal MP, Mehrotra NS, Bhatt K, Goswami S, Babalola YO, Noman A.

Oman J Ophthalmol. 2017 Sep-Dec;10(3):213-219. doi: 10.4103/ojo.OJO_42_2016.

18.

Catalytic Degradation of Dichlorvos Using Biosynthesized Zero Valent Iron Nanoparticles.

Mehrotra N, Tripathi RM, Zafar F, Singh MP.

IEEE Trans Nanobioscience. 2017 Jun;16(4):280-286. doi: 10.1109/TNB.2017.2700232. Epub 2017 May 2.

PMID:
28475065
19.

Use of statistical and pharmacokinetic-pharmacodynamic modeling and simulation to improve decision-making: A section summary report of the trends and innovations in clinical trial statistics conference.

Kimko H, Berry S, O'Kelly M, Mehrotra N, Hutmacher M, Sethuraman V.

J Biopharm Stat. 2017;27(3):554-567. doi: 10.1080/10543406.2017.1289956. Epub 2017 Feb 7.

PMID:
28304215
20.

Efficacy of Natural and Allopathic Antimicrobial Agents Incorporated onto Guided Tissue Regeneration Membrane Against Periodontal Pathogens: An in vitro Study.

Mehrotra N, Reddy Palle A, Kumar Gedela R, Vasudevan S.

J Clin Diagn Res. 2017 Jan;11(1):ZC84-ZC87. doi: 10.7860/JCDR/2017/23851.9227. Epub 2017 Jan 1.

21.

Diagnostic and Therapeutic Challenges.

Mehrotra N, Nagpal M, Shukla C, Lin P.

Retina. 2016 Dec 20. doi: 10.1097/IAE.0000000000001365. [Epub ahead of print] No abstract available.

PMID:
28002267
22.

RETINAL FINDINGS IN A CASE OF PRESUMED CUTIS MARMORATA TELANGIECTATICA CONGENITA.

Taleb EA, Nagpal MP, Mehrotra NS, Bhatt K.

Retin Cases Brief Rep. 2018 Fall;12(4):322-325. doi: 10.1097/ICB.0000000000000492.

PMID:
27930432
23.

Esomeprazole FDA Approval in Children With GERD: Exposure-Matching and Exposure-Response.

Earp JC, Mehrotra N, Peters KE, Fiorentino RP, Griebel D, Lee SC, Mulberg A, Röhss K, Sandström M, Taylor A, Tornøe CW, Wynn EL, Van der Walt JS, Garnett C.

J Pediatr Gastroenterol Nutr. 2017 Sep;65(3):272-277. doi: 10.1097/MPG.0000000000001467.

PMID:
27875488
24.

Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational Agents.

Chuk MK, Mulugeta Y, Roth-Cline M, Mehrotra N, Reaman GH.

Clin Cancer Res. 2017 Jan 1;23(1):9-12. doi: 10.1158/1078-0432.CCR-16-1367. Epub 2016 Oct 25.

25.

Rendering the 3 + 3 Design to Rest: More Efficient Approaches to Oncology Dose-Finding Trials in the Era of Targeted Therapy.

Nie L, Rubin EH, Mehrotra N, Pinheiro J, Fernandes LL, Roy A, Bailey S, de Alwis DP.

Clin Cancer Res. 2016 Jun 1;22(11):2623-9. doi: 10.1158/1078-0432.CCR-15-2644.

26.

Splinting of Longitudinal Fracture: An Innovative Approach.

Bansal R, Chowdhary P, Gurtu A, Mehrotra N, Kishore A.

Case Rep Dent. 2016;2016:5083874. doi: 10.1155/2016/5083874. Epub 2016 May 9.

27.

Management of Grossly Decayed Mandibular Molar with Different Designs of Split Cast Post and Core.

Bansal R, Mehrotra N, Chowdhary P, Gurtu A.

Case Rep Dent. 2016;2016:2976941. doi: 10.1155/2016/2976941. Epub 2016 Apr 10.

28.

Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.

Mehrotra N, Bhattaram A, Earp JC, Florian J, Krudys K, Lee JE, Lee JY, Liu J, Mulugeta Y, Yu J, Zhao P, Sinha V.

Drug Metab Dispos. 2016 Jul;44(7):924-33. doi: 10.1124/dmd.116.069559. Epub 2016 Apr 14. Review.

PMID:
27079249
29.

Persistent Mullerian Duct Syndrome with Ovarian Endometriosis-A Rare Case Report.

Nerune SM, Hippargi SB, Mestri NB, Mehrotra NM.

J Clin Diagn Res. 2016 Feb;10(2):ED14-5. doi: 10.7860/JCDR/2016/16691.7266. Epub 2016 Feb 1.

30.

In Vivo Assessment of Choroid in Diabetic Retinopathy by Enhanced Depth Imaging in Spectral Domain Optical Coherence Tomography.

Verma A, Nagpal M, Mehrotra N.

Asia Pac J Ophthalmol (Phila). 2016 Sep-Oct;5(5):319-23. doi: 10.1097/APO.0000000000000204.

PMID:
27010127
31.

Exposure-Response of Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients.

Wang J, Mehrotra N, Kim I, Lee SC, Sohrabi F, He R, Mulberg A, Sinha V, Ahn HY, Bashaw D, Griebel D.

J Pediatr Gastroenterol Nutr. 2016 Oct;63(4):412-6. doi: 10.1097/MPG.0000000000001173.

PMID:
26913757
32.

Utility of Exposure-Response Analysis in Regulatory Decision on the Selection of Starting Dose of Pasireotide for Cushing Disease.

Yu J, Chung S, Zadezensky I, Hu K, Darstein C, Nedelman J, Mehrotra N.

J Clin Pharmacol. 2016 Aug;56(8):1035-8. doi: 10.1002/jcph.694. Epub 2016 Feb 10. No abstract available.

PMID:
26686944
33.

Short interfering RNA therapeutics: nanocarriers, prospects and limitations.

Mehrotra N, Tripathi RM.

IET Nanobiotechnol. 2015 Dec;9(6):386-95. doi: 10.1049/iet-nbt.2015.0018. Review.

PMID:
26647816
34.

On the formation of SFn (-) (n = 1-6) anions via a novel route and their properties.

Mane R, Mehrotra N, Maity DK, Gupta AK.

Rapid Commun Mass Spectrom. 2015 Jul 30;29(14):1317-27. doi: 10.1002/rcm.7225.

PMID:
26405793
35.

FDA Approval: Blinatumomab.

Przepiorka D, Ko CW, Deisseroth A, Yancey CL, Candau-Chacon R, Chiu HJ, Gehrke BJ, Gomez-Broughton C, Kane RC, Kirshner S, Mehrotra N, Ricks TK, Schmiel D, Song P, Zhao P, Zhou Q, Farrell AT, Pazdur R.

Clin Cancer Res. 2015 Sep 15;21(18):4035-9. doi: 10.1158/1078-0432.CCR-15-0612.

36.

LEUKEMIC OPTIC NERVE INFILTRATION IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.

Nagpal MP, Mehrotra NS, Mehta RC, Shukla CK.

Retin Cases Brief Rep. 2016 Spring;10(2):127-30. doi: 10.1097/ICB.0000000000000187.

PMID:
26267525
37.

Reporting guidelines for population pharmacokinetic analyses.

Dykstra K, Mehrotra N, Tornøe CW, Kastrissios H, Patel B, Al-Huniti N, Jadhav P, Wang Y, Byon W.

J Clin Pharmacol. 2015 Aug;55(8):875-87. doi: 10.1002/jcph.532.

PMID:
26148467
38.

Evaluation of Wound Morphology of Sclerotomy Sites of Sutureless Vitrectomy Using Spectralis Anterior Segment Optical Coherence Tomography.

Nagpal M, Paranjpe G, Mehrotra N.

Asia Pac J Ophthalmol (Phila). 2014 May-Jun;3(3):198-9. doi: 10.1097/APO.0000000000000067. No abstract available.

PMID:
26107591
39.

Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium.

Heller S, Darpö B, Mitchell MI, Linnebjerg H, Leishman DJ, Mehrotra N, Zhu H, Koerner J, Fiszman ML, Balakrishnan S, Xiao S, Todaro TG, Hensley I, Guth BD, Michelson EL, Sager P.

Am Heart J. 2015 Jul;170(1):23-35. doi: 10.1016/j.ahj.2015.03.007. Epub 2015 Mar 18. Review.

PMID:
26093861
40.

Actinomycosis of eye: Forgotten but not uncommon.

Mehrotra N, Baidya A, Brijwal M, Aggarwal R, Chaudhry R.

Anaerobe. 2015 Oct;35(Pt B):1-2. doi: 10.1016/j.anaerobe.2015.06.001. Epub 2015 Jun 6.

PMID:
26057988
41.

Reporting guidelines for population pharmacokinetic analyses.

Dykstra K, Mehrotra N, Tornøe CW, Kastrissios H, Patel B, Al-Huniti N, Jadhav P, Wang Y, Byon W.

J Pharmacokinet Pharmacodyn. 2015 Jun;42(3):301-14. doi: 10.1007/s10928-015-9417-1. Epub 2015 Apr 30.

42.

Angiographic and spectral domain optical coherence tomography features in case of Vogt-Koyanagi-Harada disease.

Nagpal MP, Bhatt KJ, Mehrotra NS, Goswami SD.

Indian J Ophthalmol. 2015 Feb;63(2):162-3. doi: 10.4103/0301-4738.154403. No abstract available.

43.

FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma.

Lee HZ, Kwitkowski VE, Del Valle PL, Ricci MS, Saber H, Habtemariam BA, Bullock J, Bloomquist E, Li Shen Y, Chen XH, Brown J, Mehrotra N, Dorff S, Charlab R, Kane RC, Kaminskas E, Justice R, Farrell AT, Pazdur R.

Clin Cancer Res. 2015 Jun 15;21(12):2666-70. doi: 10.1158/1078-0432.CCR-14-3119. Epub 2015 Mar 23.

44.

Primary posterior capsulectomy with anterior vitrectomy in adult traumatic cataracts.

Mehrotra N, Paranjpe G.

Indian J Ophthalmol. 2015 Jan;63(1):82-3. doi: 10.4103/0301-4738.151498. No abstract available.

45.

Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.

Venkatakrishnan K, Friberg LE, Ouellet D, Mettetal JT, Stein A, Trocóniz IF, Bruno R, Mehrotra N, Gobburu J, Mould DR.

Clin Pharmacol Ther. 2015 Jan;97(1):37-54. doi: 10.1002/cpt.7. Epub 2014 Dec 9. Review.

PMID:
25670382
46.

FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma.

Miller BW, Przepiorka D, de Claro RA, Lee K, Nie L, Simpson N, Gudi R, Saber H, Shord S, Bullock J, Marathe D, Mehrotra N, Hsieh LS, Ghosh D, Brown J, Kane RC, Justice R, Kaminskas E, Farrell AT, Pazdur R.

Clin Cancer Res. 2015 Apr 1;21(7):1525-9. doi: 10.1158/1078-0432.CCR-14-2522. Epub 2015 Feb 2.

47.

Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimization.

Khurana M, Vaidyanathan J, Marathe A, Mehrotra N, Sahajwalla CG, Zineh I, Jain L.

J Clin Pharmacol. 2015 Jun;55(6):647-56. doi: 10.1002/jcph.466. Epub 2015 Feb 16. Review.

PMID:
25612234
48.

FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease.

Deisseroth A, Ko CW, Nie L, Zirkelbach JF, Zhao L, Bullock J, Mehrotra N, Del Valle P, Saber H, Sheth C, Gehrke B, Justice R, Farrell A, Pazdur R.

Clin Cancer Res. 2015 Mar 1;21(5):950-4. doi: 10.1158/1078-0432.CCR-14-1678. Epub 2015 Jan 19. Review.

49.

Attitudes of South Asian women to breast health and breast cancer screening: findings from a community based sample in the United States.

Poonawalla IB, Goyal S, Mehrotra N, Allicock M, Balasubramanian BA.

Asian Pac J Cancer Prev. 2014;15(20):8719-24.

50.

Morphometric analysis of fovea with spectral-domain optical coherence tomography and visual outcome postsurgery for retinal detachment.

Nagpal M, Shakya K, Mehrotra N, Kothari K, Bhatt K, Mehta R, Shukla C.

Indian J Ophthalmol. 2014 Aug;62(8):846-50. doi: 10.4103/0301-4738.141037.

Supplemental Content

Loading ...
Support Center